In the US, Valcyte (valganciclovir systemic) is a member of the drug class purine nucleosides and is used to treat CMV Prophylaxis and CMV Retinitis.
Ingredient matches for Valcyte
Valganciclovir is reported as an ingredient of Valcyte in the following countries:
Valganciclovir hydrochloride (a derivative of Valganciclovir) is reported as an ingredient of Valcyte in the following countries:
- Croatia (Hrvatska)
- Czech Republic
- Hong Kong
- New Zealand
- Russian Federation
- South Africa
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.